[1]
“FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease”, Clinics, vol. 77, p. 100084, Jul. 2022, doi: 10.1016/j.clinsp.2022.100084.